Dickkopf-1 as a promising therapeutic target for autoimmune diseases
- 17 October 2022
- journal article
- review article
- Published by Elsevier in Clinical Immunology
- Vol. 245, 109156
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Anhui Province (KJ2021A0230)
- Natural Science Foundation of Anhui Province (2108085Y26)
- National Natural Science Foundation of China (81872687)
This publication has 144 references indexed in Scilit:
- The Role for Dickkopf-Homolog-1 in the Pathogenesis of Crohn’s Disease-Associated FistulaePLOS ONE, 2013
- M2 Macrophages Activate WNT Signaling Pathway in Epithelial Cells: Relevance in Ulcerative ColitisPLOS ONE, 2013
- High disease activity in ankylosing spondylitis is associated with increased serum sclerostin level and decreased wingless protein-3a signaling but is not linked with greater structural damageBMC Musculoskeletal Disorders, 2013
- Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitisBMC Musculoskeletal Disorders, 2012
- Polyclonal CD4+Foxp3+ Treg cells induce TGFβ-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndromeJournal of Molecular Cell Biology, 2012
- Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosionArthritis Research & Therapy, 2010
- Identification of small-molecule inducers of pancreatic β-cell expansionProceedings of the National Academy of Sciences, 2009
- What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?Arthritis Research & Therapy, 2009
- Developments in the scientific and clinical understanding of the spondyloarthritidesArthritis Research & Therapy, 2009
- Function and biological roles of the Dickkopf family of Wnt modulatorsOncogene, 2006